- DKK20.84bn
- DKK20.71bn
- DKK6.04bn
Brief: Us FDA Says Ambu Inc Removes Spur II Resuscitators Due To Blocked Manometer Port
Brief: Ambu Q3 EBIT Before Special Items At DKK 170 Mln
Ambu rises as FDA issues import alerts on rival devices
Brief: Ambu Obtains FDA Clearance For Single-Use Flexible Cysto-Nephroscopy Solution
Ambu drops 10% to bottom of STOXX after Q2 miss
Brief: Ambu Q2 Organic Revenue Growth At 11.7%
Europe Research Roundup: Admiral, Dowlais Group, Tullow Oil
Ambu shares fall after Q1 net profit, FCF miss
Brief: Ambu Q1 EBIT Before Special Items Widens To DKK 243 Mln
Ambu tops STOXX on outlook hike, strong Q1 prelims
Brief: Ambu Raises Outlook For 2024/25
Top of the Street: Shell, Repsol, Ambu, SSE, DSM-Firmenich
Carnegie ups Ambu to 'buy' after recent selloff
JPM sees challenges to continue for European medtech & services in H1
Ambu slumps to bottom of STOXX on Q4 organic growth, EBIT misses
Brief: Ambu Launches HD Cystoscopy Solution In US
Europe Research Roundup: Carnival, Kingfisher, Unite Group
Ambu slumps as Endoscopy segment lags expectations
Brief: Ambu Q3 Adjusted EBIT DKK 178 Million Vs. Estimate DKK 178 Million